1 completed, 1 recruiting. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow Austin Neuromuscular Center: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis Pozelimab/Cemdisiran - Sporadic Inclusion Body Myositis (sIBM), Idiopathic Inflammatory Myopathies | Early Phase 1 | Recruiting | Austin Neuromuscular Center | 10 | 2024-08-08 | 2026-01-16 |
| Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy patisiran - Polyneuropathies, Wild Type ATTR Amyloidosis | Early Phase 1 | Completed | Austin Neuromuscular Center | 10 | 2022-08-03 | 2026-05-22 |
Amyloid Neuropathies, Familial (1) · Amyloidosis, Hereditary, Transthyretin-Related (1) · Myositis (1) · Myositis, Inclusion Body (1) · Polyneuropathies (1)
patisiran (1)
United States (2)